Skip to main content

Table 3 Deterioration, Non-response, Minimal Response and Remission Rates

From: A comparison of the characteristics and treatment outcomes of migrant and Australian-born users of a national digital mental health service

 

Bootstrapped PHQ9 categories of ∆@ Pre-Post

Nonresponse (−30 to 30%)

Deterioration (> − 30%)

Differences in proportions from AusBorn group (Bootstrapped p-values)

Remission (> 50%)

Minimal Response (30–50%)

Remission

Minimal Response

Nonresponse

Deterioration

NESB MidEast

64%

20%

16%

0%

.41

.88

.56

.99

NESB Europe

56%

13%

25%

6%

.92

.19

.35

.70

NESB Asia

62%

22%

12%

4%

.18

.46

.035

.67

NESB English

58%

23%

14%

6%

.58

.16

.017

.53

ESB English

61%

19%

18%

3%

.019

.89

.073

.061

Aus Born

56%

19%

21%

5%

 

Bootstrapped GAD7 categories of ∆@ Pre-Post

Nonresponse

Deterioration

Differences in proportions from AusBorn group (Bootstrapped p-values)

Remission

Minimal Response

Remission

Minimal Response

Nonresponse

Deterioration

NESB MidEast

70%

17%

13%

0%

.18

.88

.36

.99

NESB Europe

51%

24%

20%

6%

.42

.26

.81

.79

NESB Asia

68%

14%

14%

4%

.012

.25

.093

.58

NESB English

53%

17%

23%

7%

.39

.50

.42

.11

ESB English

57%

21%

19%

4%

.61

.20

.25

.19

Aus Born

56%

19%

21%

5%

  1. Note. Categories classified as deterioration (> − 30%), non-response (−30 to 30%), minimal response (30 to 50%) and remission (> 50%); Aus Australian, ESB English Speaking Background, Europe Europe region, GAD7 Generalised Anxiety Disorder Scale (7-item), MidEast Middle Eastern or North African Region, NESB Non-English Speaking Background, PHQ9 Patient Health Questionnaire (9-item), Pre-Post Pre-treatment to Post-treatment